Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mirabegron”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02476175
What this trial is testing

Add-on Mirabegron in Pediatric Patients With Refractory Overactive Bladder

Who this might be right for
Overactive BladderUrinary Incontinence
CHU de Quebec-Universite Laval 35
Large-scale testing (Phase 3)UnknownNCT05490082
What this trial is testing

Mirabegron, Propevirine, Solifenacin for Treatment of Lower Urinary Tract Symptoms During Intravesical BCG Instillation

Who this might be right for
Voiding Disorders
Mansoura University 100
Not applicableActive Not RecruitingNCT07259148
What this trial is testing

Behavioral Interventions Versus Pelvic Floor Muscle Therapy as Adjuncts to Anticholinergic Pharmacotherapy for Urgency Urinary Incontinence: A Non-Inferiority Trial

Who this might be right for
Urgency Urinary Incontinence
Emilio José Dávila Álvarez 80
Early research (Phase 1)Study completedNCT01579461
What this trial is testing

Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy Subjects

Who this might be right for
PharmacokineticsHealthy SubjectsMild and Moderate Hepatic Impairment
Astellas Pharma Europe B.V. 32
Testing effectiveness (Phase 2)Study completedNCT06133075
What this trial is testing

Using Mirabegron to Increase BP in Patients With POTS

Who this might be right for
Postural Orthostatic Tachycardia SyndromeChronic Orthostatic IntoleranceSyncope
Cedars-Sinai Medical Center 20
Not applicableStudy completedNCT06123364
What this trial is testing

Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Overactive Bladder

Who this might be right for
Overactive BladderOveractive Bladder Syndrome
Serdinsek Tamara 56
Early research (Phase 1)Study completedNCT01663961
What this trial is testing

Evaluate the Effect of a Single Dose of Digoxin on the Actions in the Bodies of Healthy Subjects After Having Taken Several Doses of YM178

Who this might be right for
Healthy
Astellas Pharma Europe B.V. 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07566208
What this trial is testing

Using Mirabegron to Control Arrhythmia-1

Who this might be right for
Ventricular Arrhythmias and Cardiac Arrest
Cedars-Sinai Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00527033
What this trial is testing

YM178 in Patients With Symptomatic Overactive Bladder

Who this might be right for
Urinary Bladder, Overactive
Astellas Pharma Inc 842
Early research (Phase 1)Study completedNCT01199523
What this trial is testing

Evaluate the Effect of Oral Mirabegron on the Heart in Healthy Males and Females

Who this might be right for
Healthy Subjects
Astellas Pharma Inc 352
Very early researchStudy completedNCT05880862
What this trial is testing

Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls

Who this might be right for
Urinary Bladder, OveractiveUrinary IncontinenceAccidental Falls
The University of Texas Medical Branch, Galveston 48
Large-scale testing (Phase 3)Looking for participantsNCT06551246
What this trial is testing

Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)

Who this might be right for
Urinary Incontinence in Children
University of Aarhus 236
Early research (Phase 1)Study completedNCT01720212
What this trial is testing

Study to Assess the Safety and Plasma Concentration of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese Volunteers

Who this might be right for
Healthy Chinese Volunteers
Astellas Pharma China, Inc. 24
Not applicableStudy completedNCT07566416
What this trial is testing

MIRABEGRON AND UAS OUTCOMES DURING RIRS

Who this might be right for
Kidney StoneRetrograde Intrarenal Surgery (RIRS)Ureteral Access Sheath
Ankara Training and Research Hospital 131
Early research (Phase 1)Study completedNCT01489696
What this trial is testing

Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin

Who this might be right for
CardiovascularHealthy SubjectsPharmacokinetics
Astellas Pharma Inc 48
Early research (Phase 1)Study completedNCT05767632
What this trial is testing

Bioequivalence Study of Solifenacin Succinate & Mirabegron From Mirfenacin MR 5/50 mg Extended Release Tablets (Hikma Pharma, Egypt) Versus Vesicare 5 mg FCT & Betmiga 50 mg Prolonged-Release Tablets (Astellas Pharma Europe B.V, the Netherlands / Astellas Pharma Europe B.V, the Netherlands)

Who this might be right for
Healthy
Genuine Research Center, Egypt 30
Early research (Phase 1)Study completedNCT00776516
What this trial is testing

Pharmacokinetic Interaction Study to Assess the Effect of Repeat Doses of Rifampin on Mirabegron (YM178) in Healthy Volunteers

Who this might be right for
Pharmacokinetics of YM178
Astellas Pharma Inc 24
Post-approval studies (Phase 4)UnknownNCT02361502
What this trial is testing

MIrabegron With oveRACtive bLadder Symptoms in mEn

Who this might be right for
Overactive Bladder
Seoul National University Hospital 462
Early research (Phase 1)Study completedNCT01284309
What this trial is testing

Assess Intraocular Pressure and Ocular Safety of the Beta-3 Agonist Mirabegron in Research Subjects

Who this might be right for
Intraocular Pressure
Astellas Pharma Inc 321
Post-approval studies (Phase 4)Study completedNCT04562090
What this trial is testing

A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder

Who this might be right for
Urge IncontinenceOveractive Bladder (OAB)
Astellas Pharma China, Inc. 249
Next Page